CERN Accelerating science

NEWS!

• 09/2026

The next phase PRISMAP+ of the European medical radionuclides programme, medical-radionuclides.eu, is now online and calls for projects using radionuclides, some from MEDICIS, and providing access to biomedical facilities. Browse the services, or ask for new radionuclides! MEDICIS will be providing some interesting radionuclides, such as High Molar Activity Sm-153, Tb-155, Er-169 produced in partners centers, and Ra-223 and Ra-224 from irradiated targets during LS3.

• 04/2026

The Programme for 2026 has restarted with mass separation of external targets or long-lived CERN sources, with an exciting scientific programme ahead combining proof-of-concept and clinical translation of MEDICIS High Molar Activity grade radionuclides.

• 01/2026

Happy new year from the MEDICIS team and support groups !

• 01/2026

PRISMAP has delivered its last radionuclide last December, the programme coordinated by CERN with MEDICIS mass separation had been a large success, as reported now on CERN website .

JOB OPPORTUNITIES

Inorganic Radiopharmaceutical Chemist -  Staff (assistant level) at Dpt Nucl Sciences Engineering (DECN), Instituto Superior Técnico (IST), University of Lisbon. Sept 30 - inquiries towards Dr. Antonio Paulo.

e